Target intelligence / Profile preview

Phosphatidylserine receptor (Ptdsr) (Ptdsr)

Target
Ptdsr
Molecular classification
Receptor, Immunoglobulin superfamily protein (Tim4), Tyrosine kinase receptor (TAM family), Transmembrane protein, Nuclear protein (for Ptdsr)
01

Overview

The term phosphatidylserine receptor generally refers to cell-surface or nuclear receptors that recognize and bind to phosphatidylserine (PS), which becomes exposed on apoptotic cells. Recognition and binding to PS is a key step in the process of efferocytosis, allowing macrophages and other phagocytes to engulf and clear dying cells while releasing anti-inflammatory mediators (such as TGF-β1). The original molecule termed "phosphatidylserine receptor" (Ptdsr) was characterized as a transmembrane protein mediating recognition and engulfment of apoptotic cells. Its loss in animals causes severe developmental defects, but evidence is mixed as to its direct role in phagocytosis, and recent data suggest additional nuclear functions and equivocal roles in cell clearance. Several other proteins (notably Tim4, BAI1, Stabilin-2, and the TAM family of receptor tyrosine kinases: Tyro3, Axl, and MerTK) function as principal "phosphatidylserine receptors" in various tissues and cell types. This ambiguity should be considered when extracting information for drug discovery or functional annotation.

Other names
PSRPtdsrTim4 (T-cell immunoglobulin and mucin domain-containing protein 4)BAI1Stabilin-2TAM receptors (Tyro3, Axl, MerTK)
02

Mechanism of action

Stimulation or inhibition of efferocytosis (apoptotic cell uptake), immune modulation, and inhibition of inflammation.

03

Biological functions

Apoptotic cell clearance (efferocytosis)Immune response regulationAnti-inflammatory signalingModulation of developmental processes
04

Disease associations

InflammationAutoimmune diseaseCancerNeurodegenerative diseaseDevelopmental defects
05

Safety considerations

Impaired clearance of apoptotic cells leads to autoimmunity or chronic inflammationInhibition can suppress beneficial immune regulation, while overstimulation risks defective immune defense or tumor immune evasion

Beyond the preview

Go deeper on Phosphatidylserine receptor (Ptdsr) (Ptdsr).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylserine receptor (Ptdsr) (Ptdsr).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call